دورية أكاديمية
An Update on Overall Survival (Os) and Follow-On Therapies in Break-3, a Phase Iii, Randomized Trial: Dabrafenib (D) Vs. Dacarbazine (Dtic) in Patients (Pts) with Braf V600E Mutation-Positive Metastatic Melanoma (Mm)
| العنوان: | An Update on Overall Survival (Os) and Follow-On Therapies in Break-3, a Phase Iii, Randomized Trial: Dabrafenib (D) Vs. Dacarbazine (Dtic) in Patients (Pts) with Braf V600E Mutation-Positive Metastatic Melanoma (Mm) |
|---|---|
| المؤلفون: | Hauschild, A., Grobb, J., Demidov, L., Jouary, T., Gutzmer, R., Millward, M., Rutkowski, P., Blank, C., Miller, W., Martin-Algarra, S., Karaszewska, B., Mauch, C., Chiarion Sileni, V., Aktan, G., Haney, P., Jin, F., Legos, J., Swann, S., Chapman, P. |
| المصدر: | Annals of Oncology ; volume 25, page iv378 ; ISSN 0923-7534 |
| بيانات النشر: | Elsevier BV |
| سنة النشر: | 2014 |
| المجموعة: | ScienceDirect (Elsevier - Open Access Articles via Crossref) |
| مصطلحات موضوعية: | Oncology, Hematology |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| DOI: | 10.1093/annonc/mdu344.8 |
| الإتاحة: | https://doi.org/10.1093/annonc/mdu344.8Test https://api.elsevier.com/content/article/PII:S0923753419525443?httpAccept=text/xmlTest https://api.elsevier.com/content/article/PII:S0923753419525443?httpAccept=text/plainTest http://academic.oup.com/annonc/article-pdf/25/suppl_4/iv378/9691345/mdu344.8.pdfTest |
| حقوق: | https://www.elsevier.com/tdm/userlicense/1.0Test/ ; http://www.elsevier.com/open-access/userlicense/1.0Test/ |
| رقم الانضمام: | edsbas.791398CC |
| قاعدة البيانات: | BASE |
| DOI: | 10.1093/annonc/mdu344.8 |
|---|